Publications by Dr Despina Televantou - ePrints

Browsing publications by Dr Despina Televantou.

Newcastle Authors	Title	Year
Dr David Meikle Professor Fai Ng Dr Despina Televantou Dr Katrina Wood Dr Christopher Bacon et al.	Extranodal marginal zone lymphoma as the presenting feature of paediatric Sjögren syndrome	2023
Dr Alex Newman Dr Masood Zaka Dr Peixun Zhou Dr Alex Blain Dr Amy Erhorn et al.	Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma	2022
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al.	Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?	2022
Emily Glover Dr Ally Speight Dr Despina Televantou Dr Stephanie Needham Professor Neil Sheerin et al.	Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report	2020
Dr Richard Noble Dr Natalie Bell Dr Helen Blair Huw Thomas Nicole Phillips et al.	Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and burkitt lymphoma	2017
Dr Nicola Cresti Dr Despina Televantou Dr David Jamieson Dr Mark Verrill Professor Alan Boddy et al.	Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cance	2016
Dr Sari Alhasan Dr Beate Haugk Laura Ogle Dr Gary Beale Anna Long et al.	Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma	2016
Liam Cornell Dr Joanne Martin Laura Ogle Dr Catherine Willoughby Dr Despina Televantou et al.	DNA-PK-A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival	2015
Dr Despina Televantou Dr Clifford Lawrence	Epstein-Barr virus-associated mucocutaneous ulceration	2014
Anna Whitehead Dr Gillian Patman Liam Cornell Dr Despina Televantou Professor Nicola Curtin et al.	A Role for DNA Repair Protein Kinase (DNA-PK) in the Progression of Simple Steatosis to Steatohepatitis (NASH)?	2013
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Fiona Oakley et al.	Mild Steatosis and Impaired Glucose Tolerance are Associated with Liver Cancer Development, While Progression to Nash Increases Number/Size in an Animal Model of NAFLD	2013
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Alastair Burt et al.	Sulfatase-2 (SULF2) Expressed in Hepatocytes and Stromal Cells Contributes to the Development of Steatosis, the Progression of NAFLD to Fibrosis and the Advancement of Cancer	2013